Biochemistry and genetics of monoamine oxidase

Pharmacology and Therapeutics

Volumn 47, Issue 3, 1990, Pages 391-417

  Weyler, Walter ^a   Hsu, Yun Pung P ^b,c   Breakafield, Xandra O ^b,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING);

AGE; FIBROBLAST; GENETICS; HUMAN; PRIORITY JOURNAL; REVIEW; THROMBOCYTE;

AMINO ACID SEQUENCE; ANIMAL; HUMAN; MOLECULAR SEQUENCE DATA; MONOAMINE OXIDASE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025074333     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/0163-7258(90)90064-9     Document Type: Article

References (301)

1. Studies of monoamine oxidases
2. Monoamine oxidase in Nippostrongylus braziliensis
3. Influence of drugs on the firing of serotonin-containing neurons in brain
4. 11C] deprenyl
5. Pig hearts lipoamide dehydrogenase and human erythrocyte glutathione reductase-homology in each of the three domains
6. cDNA cloning of human liver monoamine oxidase A and B: Molecular basis of differences in enzymatic properties
7. Monoamine oxidase in the eye, brain, and whole embryo of developing Xenopus laevis
8. Effects of nondenaturating zwitterionic detergent CHAPS, 3-[(3-cholamido propyl) dimethyl ammonio]-1-propanesulfonate, on rat liver mitochondrial and microsomal monoamine oxidase
9. The development of monoamine oxidase, glutamate decarboxylase and choline acetyltransferase in the guinea pig brain
10. Studies of enzyme-mediated reactions Part 10 Stereochemical course of the dehydrogenation of stereospecifically labelled 1-aminoheptanes by the amine oxidase from rat liver mitochondria (EC 1434)
11. Membrane enzyme development in nerve ending mitochondria during neonatal hypothyroidism
12. Deuterium isotope effects in relation to the chemical mechanism of monoamine oxidase
13. The absolute optical specificity of monoamine oxidase
14. Stereochemical aspects of MAO interactions: reversible and selective inhibitors of monoamine oxidase
15. Overview of the present state of MAO inhibitors
16. Monoclonal antibodies to monoamine oxidase B and another mitochondrial protein from human liver
17. Adverse effects of antidepressant drugs. Part 1: monoamine oxidase inhibitors and tricyclics
18. Introduction and historical background
19. The effect of neonatal 6-hydroxydopamine treatment on synaptogenesis in the visual cortex of the rat
20. Effect of riboflavin on monoamine oxidase activity in cultured neuroblastoma cells
21. Construction of a genetic linkage map in man using restriction fragment length polymorphisms
22. Monoamine oxidase type A in fibroblasts from patients with bipolar depressive illness
23. Variations in MAO and NGF in cultured human skin fibroblasts
24. Platelet monoamine oxidase: Studies of activity and thermolability in a general population
25. Molecular weight differences between human platelet and placental monoamine oxidase
26. Investigations of the mechanism of selective inhibition of Type B mitochondrial monoamine oxidase by phosphatidylserine
27. Selective effects on catalysis by the multiple forms of monoamine oxidase produced by interactions of acidic phospholipids with mitochondrial membranes
28. Proteases as probes of mitochondrial monoamine oxidase topography in situ
29. Neurotransmitter-related adaptation in the central nervous system following chronic monoamine oxidase inhibitor
30. Histochemical localization of monoamine oxidase types A and B in the adrenal gland
31. Differences in the A and B forms of monoamine oxidase revealed by limited proteolysis and peptide mapping
32. Differences in the structure of monoamine oxidases A and B in rat clonal cell lines
33. Differences in the structure of A and B forms of human monoamine oxidase
34. Partial amino acid sequence analysis of human placenta monoamine oxidase A and bovine liver monoamine oxidase B
35. Interaction of N-(1-nitro-4-azidophenyl)-serotonin with two types of monoamine oxidase in rat brain
36. 4-Fluoro-3-nitrophenyl azide, a selective photoaffinity label for types B monoamine oxidase
37. Photoaffinity labeling of beef liver monoamine oxidase by 4-fluoro-3-nitrophenyl azide
38. Estradiol treatment decreases type A and increases type B monoamine oxidase in specific brain stem areas and cerebellum of ovariectomized rats
39. Mitochondrial monoamine oxidase. Inactivation by pargyline. Adduct formation
40. Neurogenic influences of bilateral adrenalectomy on monoamine oxidase
41. Changes in alpha- and beta-receptor densities in rat brain as a result of treatment with monoamine oxidase inhibiting antidepressants
42. Effect of pretreatment with oestradiol, progesterone and DOPA on monoamine oxidase activity in the rat
43. The influence of age and adrenalectomy on rat heart monoamine oxidase
44. The turnover of the A- and B-forms of monoamine oxidase in rat liver
45. Properties of monoamine oxidase in control and Lesch-Nyhan fibroblasts
46. Dietary fat source influences neuronal mitochondrial monoamine oxidase activity and macronutrient selection in rat
47. Norrie disease caused by a gene deletion allowing carrier detection and prenatal diagnosis
48. The presence of the type A form of monoamine oxidase within nigrostriatal dopamine-containing neurons
49. An update on the identity crisis of monoamine oxidase: New and old evidence for the independence of MAO A and B
50. Human liver MAO-A and MAO-B separated by immunoaffinity chromatography with MAO-B specific monoclonal antibody
51. Development of multiple forms of mouse brain monoamine oxidase in vivo and in vitro
52. Brain monoamine oxidase and replacement of its coenzyme flavin in rats
53. Norrie disease resulting from a gene deletion: clinical features and DNA studies
54. Psychological characteristics corresponding to low verus high platelet monoamine oxidase activity
55. Monoamine oxidase reactivity in the human fallopian tube
56. MAO inhibitors in mental disease: their current status
57. Dexamethasone selectively increases monoamine oxidase type A in human skin fibroblasts
58. Monoamine oxidase A and B are differentially regulated by glucocorticoids and “aging” in human skin fibroblasts
59. Monoamine oxidase activity in normal and Lesch-Nyhan fibroblasts
60. Developmental aspects of rat heart monoamine oxidase
61. The characteristics and distribution of monoamine oxidase (MAO) activity in different tissues of the rainbow trout
62. Further studies on the synthesis of A-form of MAO
63. Mitochondrial monoamine oxidase 1. Purification and characterization of the bovine kidney enzyme
64. Comparison of the degradative fate of monoamine oxidase in endogenous and transplanted mitochondrial outer membrane in rat hepatocytes
65. A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain
66. Thyroidal biosynthesis of iodothyronines. II. General characteristics and purification of mitochondrial monoamine oxidase
67. Concentration dependence of the oxidation of tyramine by the two forms of rat liver mitochondrial monoamine oxidase
68. The interaction between human platelet monoamine oxidase, its monoamine substrates and oxygen
69. Titration of human brain monoamine oxidase-A and -B by clorgyline and l-deprenil
70. Platelet monoamine oxidase activity in sensation seekers
71. 11C-labeled suicide inactivators and PET
72. Platelet MAO concentration and molecular activity: I. New methods using an MAO B-specific monoclonal antibody in a radioimmunoassay
73. Submicroscopic interstitial deletion of the X chromosome explains a complex genetic syndrome dominated by Norrie disease
74. Platelet Monoamine Oxidase (MAO) Activity and Genetic Vulnerability to Bipolar (BP) Affective Illness
75. Genetics of plasma dopamine-hydroxylase (DBH), erythrocyte catechol-O-methyl-transferase (COMT), and platelet monoamine oxidase (MAO) in pedigrees of patients with affective disorders
76. Analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as monoamine oxidase substrates: a second ring is not necessary
77. Molecular properties of platelet MAO in psychiatric patients and controls
78. Clinical chemistry of monoamine oxidase
79. Segregation and linkage studies of plasma dopamine-beta-hydroxylase (DBH), erythrocyte catechol-O-methyltransferase (COMT), and platelet monoamine oxidase (MAO): possible linkage between the ABO locus and a gene controlling DBH activity
80. High-voltage electron microscopy of human diploid fibroblasts during ageing in vitro. Morphometric analysis of mitochondria
81. Determination of monoamine oxidase concentration in rat liver by inhibitor binding
82. Changes in enzyme patterns produced by high potassium concentration and dibutyryl cyclic AMP in organ cultures of sympathetic ganglia
83. Evidence for specific monoamine oxidases in human sympathetic nerve and pineal gland
84. In vitro labelling and axonal transport of monoamine oxidase in the rat basal ganglia using radioactive pargyline
85. Age related changes in the lipids of the microsomal and the mitochondrial membranes of rat liver and kidney
86. Modification of rat uterine monoamine oxidase activity by steroid hormones
87. Monoamine oxidase type A from human placental mitochondria: Isolation procedure and properties
88. Monoamine oxidase activity in several tissues of the goldfish, Carassius auratus
89. Distribution of monoamine oxidase activity in tissues of the urodeles Ambystroma tigrinum (tiger salamander) and Necturus maculosus (mudpuppy)
90. Effects of inhibitors of monoamine oxidase activity in perch (Perca flavescens) brain in vitro
91. In vivo and in vitro effects of temperature on monoamine oxidase activity in brain and other tissues of the goldfish. Carassius auratus)
92. Biochemistry and physiology of monoamine oxidase (MAO) activity in the ring dove (Streptopelia risoria)—II. Distribution of MAO in different tissues
93. Biochemistry and physiology of monoamine oxidase (MAO) activity in the ring dove (Streptopelia risoria). I. Characteristics of MAO activity in vitro
94. Tyramine oxidase I A new enzyme system in liver
95. A 70-kd protein of the yeast mitochondrial outer membrane is targeted and anchored via its extreme amino terminus
96. Monoamine oxidase A and B in cultured cells
97. Evidence for essential histidine residues in bovine liver mitochondrial monoamine oxidase
98. The oestrous cycle and monoamine oxidase activity
99. Exposure of mitochondrial outer membranes to neuraminidase selectively destroys monoamine oxidase A activity
100. The nature of the electrophoretically separable multiple forms of rat liver monoamine oxidase
101. The reaction pathway of membrane-bound rat liver mitochondrial monoamine oxidase
102. Rat liver mitochondrial monoamine oxidase, a change in the reaction mechanism on solubilization
103. Photoaffinity labeling of human placental monoamine oxidase A by 4-fluoro-3-nitrophenyl azide
104. Structural features of human monoamine oxidase A elucidated from cDNA and peptide sequences
105. Molecular genetics of the monoamine oxidases
106. Lipid-protein interactions in the multiple forms of monoamine oxidase. Enzymatic and ESR studies with purified intact rat brain mitochondria
107. The role of phospholipid in the multiple functional forms of brain monoamine oxidase
108. Kinetic studies on the catalytic mechanism of liver monoamine oxidase
109. Bovine liver mitochondrial monoamine oxidase is not an iron-dependent enzyme
110. The imprinting of adult hepatic monoamine oxidase levels and androgen responsiveness by neonatal androgen
111. Role of the pituitary in modulating hepatic monoamine oxidase activity
112. Modulation by phospholipids of monoamine oxidase purified from pig liver
113. Molecular cloning of a cDNA for rat liver monoamine oxidase
114. Stimulatory effect of reserpine on monoamine oxidase in guinea pig heart
115. Biochemical and stereological analysis of rat liver mitochondria in different thyroid states
116. Some observations upon a new inhibitor of monoamine oxidase in brain tissues
117. Blood-brain barrier monoamine oxidase: enzyme characterization in cerebral microvessels and other tissues from six mammalian species, including human
118. On hepatic mitochondrial monoamine oxidase activity in lipid deficiency
119. On the biogenesis of monoamine oxidases in hepatic mitochondira of riboflavin-deficient rats
120. Restoration of visual cortical plasticity by local microperfusion of norepinephrine
121. The covalently-bound flavin of hepatic monoamine oxidase. Isolation and sequence of a flavin peptide and evidence for binding at the 8-alpha position
122. Serotonin metabolism in the brains of mice sensitive or resistant to audiogenic seizures
123. Introduction
124. Loss of hepatic monoamine oxidase activity resulting from replacement of its coenzyme flavin (40078)
125. Covalent bonding of riboflavin homologs by hepatic mitochondrial membrane enzymes
126. A new type of mitochondrial monoamine oxidase distinct from type-A and type-B
127. Inhibition of carp liver mitochondrial monoamine oxidase by some commonly used detergents
128. Membrane lipid environment of carp brain and liver mitochondrial monoamine oxidase
129. Monoamine oxidase-containing neurons in the cat hypothalamus: distribution and ascending projection to the cerebral cortex
130. Demonstration of monoamine oxidase type B in serotonergic and type A in noradrenergic neurons in the cat dorsal pontine tegmentum by an improved histochemical technique
131. Distribution of two types of monoamine oxidase-containing neurons in the cat medulla oblongata demonstrated by an improved histochemical method
132. Critical role of MAO inhibition in Parkinson's Disease
133. Some puzzling pharmacological effects of monoamine oxidase inhibitors
134. Monoamine oxidase in frog liver and brain
135. Immunological uniqueness of human monoamine oxidases A and B. New evidence from studies with monoclonal antibodies to human monoamine oxidase A
136. Assignment of genes for human monoamine oxidases A and B to the X chromosome
137. Muscle and liver monoamine oxidases: effect of iron and riboflavin-deficiency in the rat
138. Monoamine oxidase of rat skeletal muscle: substrate specificity and half-life
139. Monoamine oxidase A and B activities in liver of riboflavin deficient rats
140. Expression of functional human monoamine oxidase A and B cDNAs in mammalian cells
141. Exogenous monoamines affect the segregation of retinogeniculate fibers in developing rats
142. 1-type dopamine receptors inhibit growth cone motility in cultured retina neurons: evidence that neurotransmitters act as morphogenic growth regulators in the developing central nervous system
143. Roles for neurotransmitters in development: possible interaction with drugs during the fetal and neonatal periods
144. Monoamine oxidase in rat and bovine endocrine tissues
145. The regional distribution of monoamine oxidase activities towards different substrates: effects in rat brain of chronic administration of manganese chloride and of ageing
146. Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons
147. Specific cellular expression of monoamine oxidase B dueing early stages of quail embryogenesis
148. Localization of human monoamine oxidase-A gene to Xp11.23–11.4 by in situ hybridization: Implications for Norrie disease
149. Development of benzylamine oxidase and monoamine oxidase A and B in man
150. Effect of oestradiol on turnover of type A monoamine oxidase in brain
151. Effect of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain
152. Effects of l-DOPA administration upon monoamine oxidase activity in rat tissues
153. Genotype dependence of monoamine oxidase in inbred strains of mice
154. Effect of dietary trans fatty acids on cholinesterase and monoamine oxidase activities in different organs of rats
155. Monoamine oxidase (MAO) activity in the marine invertebrate, Crassostrea angulata (Lmk)
156. The estrogen-responsive elements as an inducible enhancer: DNA sequence requirements and conversion to a glucocorticoid-responsive element
157. Monoamine oxidase in bovine thyroid tissue
158. Localization of monoamine oxidase (MAO) in the rat peripheral nervous system—existence of MAO-containing unmyelinated axons
159. The structure of the covalent adduct formed by the interaction of 3-dimethylamino-1-propyne and the flavin of mitochondrial amine oxidase
160. Separation of two monoamine oxidases from bovine brain
161. An update on flavin metabolism in rats and humans
162. (E)-B-fluoromethylene)-m-tyrosine: a substrate for aromatic l-amino acid decarboxylase liberating an enzyme-activated irreversible inhibitor of monoamine oxidase
163. Human liver monoamine oxidase. I. Kinetic studies of model interactions
164. Human liver monoamine oxidase. II. Determinants of substrate and inhibitor specificities
165. Human liver monoamine oxidase. III. Kinetic studies concerning time-dependent inhibitions
166. Aging and neurotransmitter systems
167. Bovine liver monoamine oxidase A modified purification procedure and preliminary evidence for two subunits and one FAD
168. Mitochondrial role in cell aging
169. Monoamine oxidase in adult Ascaridia galli
170. An improved fluorimetric assay for brain monoamine oxidase
171. Clinical, genetic, hormonal and drug influences on the activity of human platelet monoamine oxidase
172. Biological and behavioral consequences of alterations in monoamine oxidase activity
173. Substrate and inhibitor-related characteristics of monoamine oxidase in C6 rat glial cells
174. Platelet and plasma amine oxidase activity in 680 normals: Sex and age differences and stability over time
175. Marked amine and amine metabolite changes in Norrie disease patients with an X chromosome deletion affecting monoamine oxidase
176. Identity of the active site flavin-peptide fragments from the human “A”-form and bovine “B”-form of monoamine oxidase
177. Expression of A and B types in monoamine oxidase in differentiated neuroblastoma hybrid cells
178. An evaluation of phospholipids as regulators of monoamine oxidase A and monoamine oxidase B activities
179. Changes in activity of mitochondrial enzymes during the development of Xenopus laevis
180. A radiochemical evaluaion of mitochondrial monoamine oxidase activity in sea urchin eggs and embryos
181. Monoamine oxidase activity in Paracentrotus lividus sperm cells
182. Occurrence of type A and type B monoamine oxidase activities in toad egg mitochondria
183. Changes in monoamine oxidase activity by mitochondria isolated from late embryos of Bufo bufo
184. Monoamine oxidase activity in tissues of the starfish Marthasterias glacialis
185. Genetic control of platelet and plasma monoamine oxidase activity
186. Do mitochondria produce oxygen radicals in vivo
187. Responses of mitochondiral superoxide dismutase, catalase and glutathione peroxidase activities to aging
188. Electrophoretic properties of mitochondrial monoamine oxidase in monkey liver
189. Studies on B-phenylethylamine deamination by human placental monoamine oxidase
190. Mechanistic studies of beef liver mitochondrial monoamine oxidase
191. Purification and properties of pig liver mitochondrial monoamine oxidase
192. The activity of human brain and thrombocyte monoamine oxidase (MAO) in relation to various psychiatric disorders. I. MAO activity in some diseases states
193. A comparison of platelet monoamine oxidase activity and phosphatidylserine content between chronic paranoid schizophrenics and normal controls
194. Human monoamine oxidase gene (MAOA): Chromosome position (Xp21-p11) and DNA polymorphism
195. MspI RFLP for human MAOA gene
196. Inhibition of monoamine oxidase selectively in brain monoamine nerves using the bioprecursor (E)-B-fluoromethylene-m-tyrosine (MDL 72394), a substrate for aromatic l-amino acid decarboxylase
197. Reduced platelet MAO activity and vulberability to psychiatric disorders
198. The effects of metopirone and adrenalectomy on the regulation of the enzymes monoamine oxidase and catechol-o-methyl transferase in different brain regions
199. Aldimine intermediate in oxidation of amines catalyzed by mitochondrial monoamine oxidase (MAO)
200. Human brain monoamine oxidase: solubilization and kinetics of inhibition by octylglucoside
201. Human brain monoamine oxidase type B: mechanism of deamination as probed by steady-state methods
202. The influence of nerve growth factor, potassium depolarization and dibutyryl (cyclic) adenosine 3′, 5′-monophosphate on explant cultures of chick embryo sympathetic ganglia
203. Monoamine oxidase (MAO) activity as a determinant in human neurophysiology
204. Gene for monoamine oxidase type A assigned to the human X chromosome
205. Biochemical and genetic analysis of MAO A and B
206. Specificity of antisera prepared against pure bovine MAO B
207. Characterization of monoamine oxidase activity during early stages of quail embryogenesis
208. Differences in monoamine oxidase activity between cultured noradrenergic and cholinergic sympathetic neurons
209. Comparative studies of purified and reconstituted monoamine oxidase from bovine liver mitochondria
210. The primary structure of bovine monoamine oxidase type A: comparison with peptide sequences of bovine monoamine oxidase type B and other flavoenzymes
211. Central neurotransmitters and aging
212. Stopped-flow studies on the mechanism of oxidation of N-methyl-4-phenyltetrahydropyridine by bovine liver monoamine oxidase B
213. Platelet monoamine oxidase (MAO) activity: Evidence for a single major locus
214. Mechanism-based inhibitors of monoamine oxidase
215. Ageing, monoamines and monoamine-oxidase levels
216. Platelet MAO concentration and molecular activity: II. Comparison of normal and schizophrenic populations
217. Catecholamine toxicity in cerebral cortex in dissociated cell culture
218. Distribution of the two forms of monoamine oxidase within monoaminergic neurons of the guinea pig brain
219. The vectorial orientation of human monoamine oxidase in the mitochondrial outer membrane
220. Enzymatic profile of mitochondria isolated from selected brain regions of young adult and one-year-old rats
221. Regulation of multiple forms of dopamine beta-hydroxylase by nerve growth factor, dexamethasone and dibutyryl cyclic AMP in the PC12 pheochromocytoma cell line
222. In vitro synthesis of monoamine oxidase of rat liver outer mitochondrial membrane
223. Monoamine oxidase from beef liver mitochondria: simplified isolation procedure, properties, and determination of its cysteinyl flavin content
224. A specific increase in intraneuronal monoamine oxidase activity in the rat vas deferens following adrenalectomy
225. Signals guiding proteins to their correct location in mitochondria
226. The submitochondrial localization of monoamine oxidase
227. Mitochondrial monoamine oxidase activity during preneural developmental stages in Bufo Bufo
228. Monoamine oxidase in aging human brain
229. Cation exchange high-performance liquid chromatography assay for the nigrostriatal toxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its monoamine oxidase B generated metabolites in brain tissues
230. (Amino-alkyl)trimethylsilanes. A new class of monoamine oxidase inactivators
231. (Amino-alkyl)trimethylgermanes the first organogermasium mechanism-based inactivators a new class of monoamine oxidase inactivators
232. Mechanism of inactivation of monoamine oxidase by 1-phenylcyclopropylamine
233. Identification of the amino acid bound to the labile adduct formed during inactivation of monoamine oxidase by 1-phenyl-cyclopropylamine
234. 1-Phenylcyclobutylamine, the first in a new class of monoamine oxidase inactivators. Further evidence for a radical intermediate
235. A mechanism for mitochondrial monoamine oxidase catalyzed amine oxidation
236. Photochemical and photophysical studies of amines with excited flavins. Relevance to the mechanism of action of the flavin-dependent monoamine oxidase
237. Monoamine oxidase deficiency in males with an X chromosome deletion
238. The Norrie disease gene is distinct from the monoamine oxidase genes
239. Mitochondrial monoamine oxidase. Isolation, assay, properties, mechanism, and unresolved questions
240. Biochemical events in the development of Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
241. Biochemistry of the neurotoxic action of MPTP and what it may teach us about the etiology of idiopathic Parkinsonism
242. Monoamine oxidase in single nerve cell bodies from locus coeruleus of the rat. A microgasometric study
243. The processing and assembly of rat liver MAO
244. Influence of hormones, vitamins and metals on monoamine oxidase activity
245. The inhibition of A and B forms of MAO in the production of a characteristic behavioral syndrome in rats after l-tryptophan loading
246. Purification of rat liver monoamine oxidase by octyl glucoside extraction and reconstitution
247. Effects of scorpion venom on monoamine oxidase activity in the cockroach tissues
248. Phospholipid dependency of carp brain and liver mitochondrial monoamine oxidase
249. Familial biochemical and clinical correlates of alcoholics with low platelet monoamine oxidase activity
250. Oxidation of β-phenylethylamine by both types of monoamine oxidase: examination of enzymes in brain and liver of eight species
251. Differences in platelet enzyme activity between alcogolics and non-alcoholics
252. Phosphatidylserine inhibition of monoamine oxidase in platelets of schizophrenics
253. A new rapid and sensitive bioluminescence assay for monoamine oxidase activity
254. Monoamine oxidase
255. The catalytic behaviour of monoamine oxidase
256. Processing of MPTP by monoamine oxidases: implications for molecular toxicology
257. Ontogenesis of multiple forms of monoamine oxidase in rat brain regions and liver
258. Genetics of mitochondrial biogenesis
259. Assay of platelet monoamine oxidase in whole blood
260. Mitochondrial alterations in the spinal ganglion neurons in ageing rats
261. Personality traits related to monoamine oxidase activity in platelets
262. Amine oxidases and their endogenous substrates (with special reference to monoamine oxidase and the brain)
263. Kinetic probes of the proposed radical mechanism of monoamine oxidase
264. The covalently-bound flavin of hepatic monoamine oxidase. 2. Identification and properties of cysteinyl riboflavin
265. Retinal malformations
266. The topography of mitochondrial MAOs
267. Distinct monoamine oxidase A and B populations in primate brain
268. 2-Chloro-2-phenylethylamine as a mechanistic probe and active site directed inhibitor of monoamine oxidase from bovine liver mitochondria
269. Monoamine oxidase A from human placenta and monoamine oxidase from bovine liver both have one FAD per subunit. An important revision
270. Iron content and spectral properties of highly purified bovine liver monoamine oxidase
271. Purification and properties of mitochondrial monoamine oxidase type A from human placenta
272. Non-stereospecific reduction of monoamine oxidase from bovine liver by analogs of amphetamine
273. Comparison of partial amino acid sequences deduced from the nucleotide sequences of a bovine adrenal monoamine oxidase cDNA clone to amino acid sequences obtained from bovine liver monoamine oxidase type B
274. Monoamine oxidase A and B as components of a membrane complex
275. Species differences in monoamine oxidase-A and -Bas revealed by sensitivity to trypsin
276. Selective effects of proteases and phospholipase A2 on monoamine oxidase A and B of human brain and liver
277. Prediction of th occurrence of the ADP-binding beta-alpha-beta-fold in proteins, using an amino acid sequence fingerprint
278. On the stereospecificity of monoamine oxidase
279. Low platelet monoamine oxidase and vulnerability to schizophrenia
280. Steroid receptor regulated transcription of specific genes and gene networks
281. Advances in monoamine oxidase enzymology
282. Enzymic and molecular characteristics of a new form of monoamine oxidase, distinct from form-A and form-B
283. MAO type B inhibitors as adjunct to L-dopa therapy
284. Monoamine oxidase B inhibition and the “cheese effect”
285. Physiological and pathological changes in tissue monoamine oxidase activity
286. Isolated chromaffin cells from adrenal medulla contain primarily monoamine oxidase B
287. Contrasting monoamine oxidase activity and tyramine induced catecholamine release in PC12 and chromaffin cells
288. Human monoamine oxidase, lack of brain and platelet correlation
289. Studies on the pargyline-binding site of different types of monoamine oxidase
290. Some effects of non-ionic detergent Triton X-100 on rat liver monoamine oxidase
291. Differential expression of type A and B monoamine oxidase of mouse astrocytes in primary cultures
292. Stereospecific deuterium substitution at the α-carbon position of dopamine and its effect on oxidative deamination catalyzed by MAO A and MAO B from different tissues